fruticosa flowers were β-sitosterol, kaempferol, ellagic acid, octacosanol, meso-inositol, quercetin, woodfordins A, B, C, D and oenothein A and B. 22 Ellagic acid is an anticarcinogenic agent, it inhibits DNA topoisomerase. 23 Quercetin is an antioxidant possesses antiinflamatory and anticarcinogenic properties. 24 Woodfordin C and oenothein B, a

class of macrocyclic hydrolysable tannins exhibited potent host-mediated antitumor activity against sarcoma 180 in mice. 25 and 26 Torin 1 Woodfordin C showed remarkable inhibition of DNA topoisomerase II. 27 Woodfordin D and oenothein A, trimeric hydrolysable tannins also have antitumor activity. 28 The identified class of components in single or in combination with other components present in the extract might be responsible for the prevention of hepatocellular

carcinoma. The results in the present study validate the potential anticancer activity of MEWF. HCC induced by NDEA was effectively inhibited by the treatment with MEWF at a dose of 200 mg/kg, b.w. The potential antiproliferative effect of MEWF was also evidenced by human hepatoma PLC/PRF/5 cell line. The potential chemoprevention observed in this study might be due to synergistic effect of the phytomolecules present in the extract. This finding suggested a possible basis for the potential use of the flowers of W. fruticosa in the inhibition of hepatic cancer. These findings might also provide a pharmacological background on the traditional use of the

plant for the treatment of liver diseases. GSK1120212 datasheet However further work is required for the fractionation of MEWF and identification of the active compound Farnesyltransferase which is underway. All authors have none to declare. The authors would like to acknowledge for the financial support given by Mahatma Gandhi University. “
“Aceclofenac, a phenyl acetic derivative related to diclofenac, is a widely used nonsteroidal anti-inflammatory drug (NSAID). The short biological half life (4 h) and dosing frequency of more than one per day, make aceclofenac an ideal candidate for sustained release. A once daily sustained release formulation for aceclofenac is useful to reduce the frequency of administration, to minimize the gastrointestinal disturbances such as peptic ulceration with bleeding and to improve patient compliance.1 Polyethylene oxide is a high molecular weight, nonionic homopolymer of ethylene oxide with good water solubility. It has been successfully used in different drug delivery systems.2 Upon exposure to water or gastric juices, PEOs hydrate and swell rapidly to form hydrogels with properties ideally suited for a controlled drug delivery vehicle. In PEOs with molecular weight in the range of 0.6, 0.9 and 2.0 × 106, synchronization of the swelling and erosion processes was observed. In contrast, PEOs possessing a molecular weight of 4.